Monogram Biosciences to Present at the Thomas Weisel Partners Healthcare Conference 2007

Thursday, August 23, 2007 General News J E 4
SOUTH SAN FRANCISCO, Calif., Aug. 23 MonogramBiosciences, Inc. (Nasdaq: MGRM) announced today that William D. Young, CEOand Chairman, is scheduled to present a corporate overview at the ThomasWeisel Partners Healthcare Conference 2007 on Wednesday, September 5, 2007 at3:15 p.m. (Eastern Time) at the Four Seasons Hotel in Boston, Massachusetts.

To access the live audio broadcast or the subsequent archived recording,log on to and go to the investor relations section("Investors/Media" tab) and click on the "Events & Webcasts" link provided onthe sidebar menu on the page.

About Monogram Biosciences, Inc.

Monogram is advancing individualized medicine by discovering, developingand marketing innovative products to guide and improve treatment of seriousinfectious diseases and cancer. The Company's products are designed to helpdoctors optimize treatment regimens for their patients that lead to betteroutcomes and reduced costs. The Company's technology is also being used bynumerous biopharmaceutical companies to develop new and improved antiviraltherapeutics and vaccines as well as targeted cancer therapeutics. Moreinformation about the Company and its technology can be found on its web siteat Alfred G. Merriweather Chief Financial Officer Tel: 650 624-4576 Jeremiah Hall Feinstein Kean Healthcare Tel: 415 677-2700

SOURCE Monogram Biosciences, Inc.


You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
Think Women Talk About Everything? Think Again!
Progen Pharmaceuticals Announces Fiscal 2007 Finan...